Kelli Heathman

Director, Corporate Accounts and Strategic Partners
BeiGene USA

Kelli Heathman is Director of Corporate Accounts and Strategic Partners with BeiGene USA. She leads a team of Corporate Account Directors that focus on market access issues and business development in community oncology as well as IDN/ Health Systems.   

Kelli participated as the industry co-chair for NCODA (National Community Oncology Dispensing Association) Oncology Institute.  In addition to industry co-chair, Kelli was on a speaker panel discussing the Business of Oncology during the Oncology Institute Conference.

Kelli has over 20 years’ experience in the Pharma Industry primarily in Sales Leadership and Market Access.  Her Market Access experience is wide-ranging and consists of oral and IV Oncolytics, specialty pharmacy in community and hospital settings, reimbursement, regional payers, 340b, and GPO management. 

Kelli graduated from the University of North Carolina at Charlotte with a Bachelor of Science in Kinesiology.  She resides in Arkansas and is a huge fan of the Arkansas Razorbacks and SEC football.  In her spare time, Kelli trains and competes in protection sports with her Belgian Malinois.